Concepedia

Felix Bock

FB

Statistics

Publications

61

Citations

3.6K

H-Index

37

Active since

1973

Affiliations

University of Cologne(Current)

Friedrich-Alexander-Universität Erlangen-Nürnberg

University Hospital Cologne

Universitätsklinikum Erlangen

Harvard University

Felix Bock is an author at University of Cologne specializing in medicine, ophthalmology, and corneal vascularization.

Publications per year

1973–2023

61

Publications

61

Bevacizumab as a Potent Inhibitor of Inflammatory Corneal Angiogenesis and Lymphangiogenesis

Felix Bock, Jasmine Onderka, Tina Dietrich-Ntoukas et al. · Investigative Ophthalmology & Visual Science · 2007 · 320 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Cutting Edge: Lymphatic Vessels, Not Blood Vessels, Primarily Mediate Immune Rejections After Transplantation

Tina Dietrich-Ntoukas, Felix Bock, Don Yuen et al. · The Journal of Immunology · 2009 · 291 citations · Full text

Medicine, Immunology, Surgery +17

Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin®) eye drops against corneal neovascularization

Y. Koenig, Felix Bock, Folkert K. Horn et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2009 · 178 citations

Pharmacy, Ophthalmology, Pharmacotherapy +17

Bevacizumab (Avastin) eye drops inhibit corneal neovascularization

Felix Bock, Y. König, Friedrich E. Kruse et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2007 · 173 citations

Pharmacy, Ophthalmology, Pharmacotherapy +14

Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes

Claus Cursiefen, Kazuichi Maruyama, Felix Bock et al. · The Journal of Experimental Medicine · 2011 · 162 citations · Full text

Life Sciences, Cell Biology, Immunology +17

1–5 of 61